{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:16:35Z","timestamp":1785521795200,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13760-026-03024-w","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:11:44Z","timestamp":1773303104000},"page":"1105-1113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative effectiveness of cilostazol and aspirin in ischemic stroke: a retrospective cohort study"],"prefix":"10.1007","volume":"126","author":[{"given":"Yiyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"4","key":"3024_CR1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.nic.2024.08.010","volume":"34","author":"N Fileva","year":"2024","unstructured":"Fileva N, Bertamino M, Tortora D, Severino M (2024) Arterial Ischemic Stroke in Children. Neuroimaging Clin N Am Nov 34(4):579\u2013599. https:\/\/doi.org\/10.1016\/j.nic.2024.08.010","journal-title":"Neuroimaging Clin N Am Nov"},{"issue":"9","key":"3024_CR2","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.3174\/ajnr.A8307","volume":"9","author":"SB Jazayeri","year":"2024","unstructured":"Jazayeri SB, Ghozy S, Hemmeda L et al (2024) Risk of Hemorrhagic Transformation after Mechanical Thrombectomy without versus with IV Thrombolysis for Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Clinical Trials. AJNR Am J Neuroradiol Sep 9(9):1246\u20131252. https:\/\/doi.org\/10.3174\/ajnr.A8307","journal-title":"AJNR Am J Neuroradiol Sep"},{"issue":"1","key":"3024_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00270-024-03890-y","volume":"48","author":"SB Jazayeri","year":"2025","unstructured":"Jazayeri SB, Al-Janabi OM, Ghozy S, Rabinstein AA, Kadirvel R, Kallmes DF (2025) Outcomes of Mechanical Thrombectomy for Acute Ischemic Stroke Following Cardiac Interventions: A Systematic Review and Meta-Analysis. Cardiovasc Intervent Radiol Jan 48(1):45\u201358. https:\/\/doi.org\/10.1007\/s00270-024-03890-y","journal-title":"Cardiovasc Intervent Radiol Jan"},{"issue":"2","key":"3024_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.nic.2024.01.004","volume":"34","author":"S Panicker","year":"2024","unstructured":"Panicker S, Wilseck ZM, Lin LY, Gemmete JJ (2024) CT Imaging Computed Tomography\/Computed Tomography Angiography\/Perfusion in Acute Ischemic Stroke and Vasospasm. Neuroimaging Clin N Am May 34(2):175\u2013189. https:\/\/doi.org\/10.1016\/j.nic.2024.01.004","journal-title":"Neuroimaging Clin N Am May"},{"issue":"10042","key":"3024_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0140-6736(16)30468-8","volume":"388","author":"PM Rothwell","year":"2016","unstructured":"Rothwell PM, Algra A, Chen Z, Diener H-C, Norrving B, Mehta Z (2016) Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. lancet 388(10042):365\u2013375","journal-title":"lancet"},{"issue":"9990","key":"3024_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0140-6736(15)60243-4","volume":"386","author":"JL Mega","year":"2015","unstructured":"Mega JL, Simon T (2015) Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments. Lancet 386(9990):281\u2013291","journal-title":"Lancet"},{"issue":"3","key":"3024_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/STROKEAHA.118.023954","volume":"50","author":"DG Hackam","year":"2019","unstructured":"Hackam DG, Spence JD (2019) Antiplatelet therapy in ischemic stroke and transient ischemic attack: An overview of major trials and meta-analyses. Stroke 50(3):773\u2013778","journal-title":"Stroke"},{"issue":"1","key":"3024_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000327036","volume":"32","author":"Y-S Lee","year":"2011","unstructured":"Lee Y-S, Bae H-J, Kang D-W et al (2011) Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial. Cerebrovasc Dis 32(1):65\u201371","journal-title":"Cerebrovasc Dis"},{"key":"3024_CR9","doi-asserted-by":"publisher","unstructured":"Kim SM, Jung J-M, Kim BJ, Lee J-S, Kwon SU (2019) Cilostazol mono and combination treatments in ischemic stroke: an updated systematic review and meta-analysis. Stroke 50(12):3503\u20133511. https:\/\/doi.org\/10.1161\/STROKEAHA.119.026655.","DOI":"10.1161\/STROKEAHA.119.026655"},{"issue":"8","key":"3024_CR10","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1161\/STROKEAHA.120.029454","volume":"51","author":"C McHutchison","year":"2020","unstructured":"McHutchison C, Blair GW, Appleton JP et al (2020) Cilostazol for secondary prevention of stroke and cognitive decline: systematic review and meta-analysis. Stroke 51(8):2374\u20132385","journal-title":"Stroke"},{"key":"3024_CR11","doi-asserted-by":"publisher","first-page":"703258","DOI":"10.3389\/fneur.2021.703258","volume":"12","author":"JM Hong","year":"2021","unstructured":"Hong JM, Kim DS, Kim M (2021) Hemorrhagic transformation after ischemic stroke: mechanisms and management. Front Neurol 12:703258","journal-title":"Front Neurol"},{"issue":"3","key":"3024_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11936-013-0233-x","volume":"15","author":"V-A Lioutas","year":"2013","unstructured":"Lioutas V-A, Sonni S, Caplan LR (2013) Diagnosis and misdiagnosis of cerebrovascular disease. Curr Treat Options Cardiovasc Med 15(3):276\u2013287","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"5","key":"3024_CR13","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1161\/STR.0000000000000228","volume":"51","author":"Correction to","year":"2020","unstructured":"Correction to (2020) Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke. Stroke May 51(5):e99. https:\/\/doi.org\/10.1161\/STR.0000000000000228","journal-title":"Stroke May"},{"issue":"7","key":"3024_CR14","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jamaneurol.2023.1526","volume":"1","author":"JM Wardlaw","year":"2023","unstructured":"Wardlaw JM, Woodhouse LJ, Mhlanga II et al (2023) Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial. JAMA Neurol Jul 1(7):682\u2013692. https:\/\/doi.org\/10.1001\/jamaneurol.2023.1526","journal-title":"JAMA Neurol Jul"},{"key":"3024_CR15","doi-asserted-by":"publisher","unstructured":"Zhao Y, Zhang X, Chen X, Wei Y (2022) Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review). Int J Mol Med Feb 49(2). https:\/\/doi.org\/10.3892\/ijmm.2021.5070","DOI":"10.3892\/ijmm.2021.5070"},{"issue":"1","key":"3024_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/17474930211065917","volume":"17","author":"VL Feigin","year":"2022","unstructured":"Feigin VL, Brainin M, Norrving B et al (2022) World Stroke Organization (WSO): global stroke fact sheet 2022. Int J stroke 17(1):18\u201329","journal-title":"Int J stroke"},{"issue":"2","key":"3024_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2025.5716","volume":"49","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zhang X, Chen X, Wei Y (2022) Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment. Int J Mol Med 49(2):1\u20139","journal-title":"Int J Mol Med"},{"key":"3024_CR18","doi-asserted-by":"publisher","first-page":"111301","DOI":"10.1016\/j.cellsig.2024.111301","volume":"121","author":"ZR Li","year":"2024","unstructured":"Li ZR, Wang YY, Wang ZH et al (2024) The positive role of transforming growth factor-beta1 in ischemic stroke. Cell Signal Sep 121:111301. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111301","journal-title":"Cell Signal Sep"},{"issue":"21","key":"3024_CR19","doi-asserted-by":"publisher","first-page":"13638","DOI":"10.3390\/ijms232113638","volume":"23","author":"RM Chiorescu","year":"2022","unstructured":"Chiorescu RM, Mocan M, Inceu AI, Buda AP, Blendea D, Vlaicu SI (2022) Vulnerable atherosclerotic plaque: is there a molecular signature? Int J Mol Sci 23(21):13638","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3024_CR20","first-page":"e000576","volume":"3","author":"K Krishnan","year":"2023","unstructured":"Krishnan K, Nguyen TN, Appleton JP et al (2023) Antiplatelet resistance: a review of concepts, mechanisms, and implications for management in acute ischemic stroke and transient ischemic attack. Stroke: Vascular Interventional Neurol 3(3):e000576","journal-title":"Stroke: Vascular Interventional Neurol"},{"issue":"5","key":"3024_CR21","doi-asserted-by":"publisher","first-page":"e249298","DOI":"10.1001\/jamanetworkopen.2024.9298","volume":"1","author":"D Xie","year":"2024","unstructured":"Xie D, Huang J, Fan S et al (2024) Endovascular Therapy and Outcomes Among Patients With Very Large Ischemic Core Stroke. JAMA Netw Open May 1(5):e249298. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.9298","journal-title":"JAMA Netw Open May"},{"issue":"2","key":"3024_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1755-5949.2011.00290.x","volume":"18","author":"YJ Wang","year":"2012","unstructured":"Wang YJ, Zhang SM, Zhang L, Wang CX (2012) Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010. CNS Neurosci Ther 18(2):93\u2013101","journal-title":"CNS Neurosci Ther"},{"key":"3024_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.vph.2016.10.006","volume":"87","author":"NW Russo","year":"2016","unstructured":"Russo NW, Petrucci G, Rocca B (2016) Aspirin, stroke and drug-drug interactions. Vascul Pharmacol 87:14\u201322","journal-title":"Vascul Pharmacol"},{"issue":"5","key":"3024_CR24","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.3390\/ijms25052593","volume":"25","author":"M Sohn","year":"2024","unstructured":"Sohn M, Lim S (2024) The role of cilostazol, a phosphodiesterase-3 inhibitor, in the development of atherosclerosis and vascular biology: a review with meta-analysis. Int J Mol Sci 25(5):2593","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3024_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/1099800420951633","volume":"23","author":"Y Kim","year":"2021","unstructured":"Kim Y, Kim Y-J (2021) Effect of obesity on cognitive impairment in vascular dementia rat model via BDNF-ERK-CREB pathway. Biol Res Nurs 23(2):248\u2013257","journal-title":"Biol Res Nurs"},{"key":"3024_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.wneu.2019.09.168","volume":"133","author":"N Fatima","year":"2020","unstructured":"Fatima N (2020) In Reply to the Letter to the Editor Regarding Decompressive Craniectomy: A Preliminary Study of Comparative Radiographic Characteristics Predicting Outcome in Malignant Ischemic Stroke. World Neurosurg Jan 133:453. https:\/\/doi.org\/10.1016\/j.wneu.2019.09.168","journal-title":"World Neurosurg Jan"},{"issue":"3","key":"3024_CR27","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1124\/jpet.103.061853","volume":"308","author":"JH Lee","year":"2004","unstructured":"Lee JH, Kim KY, Lee Y-K et al (2004) Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats. J Pharmacol Exp Ther 308(3):896\u2013903","journal-title":"J Pharmacol Exp Ther"},{"key":"3024_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.intimp.2018.06.021","volume":"62","author":"T Sakamoto","year":"2018","unstructured":"Sakamoto T, Ohashi W, Tomita K, Hattori K, Matsuda N, Hattori Y (2018) Anti-inflammatory properties of cilostazol: Its interruption of DNA binding activity of NF-\u03baB from the Toll-like receptor signaling pathways. Int Immunopharmacol 62:120\u2013131","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3024_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/0271678X15621499","volume":"37","author":"T Takagi","year":"2017","unstructured":"Takagi T, Imai T, Mishiro K et al (2017) Cilostazol ameliorates collagenase-induced cerebral hemorrhage by protecting the blood\u2013brain barrier. J Cereb Blood Flow Metabolism 37(1):123\u2013139","journal-title":"J Cereb Blood Flow Metabolism"},{"issue":"3","key":"3024_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/bc.bc_21_18","volume":"4","author":"T Knecht","year":"2018","unstructured":"Knecht T, Borlongan C, dela Pe\u00f1a I (2018) Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator. Brain circulation 4(3):99\u2013108","journal-title":"Brain circulation"},{"issue":"11","key":"3024_CR31","doi-asserted-by":"publisher","first-page":"9033","DOI":"10.1007\/s00210-024-03176-7","volume":"397","author":"NA El-Shitany","year":"2024","unstructured":"El-Shitany NA, El-Saidy EA, El-Naggar ME, Sokar SS (2024) Cilostazol protects against gastric ulcers by regulating PPAR-\u03b3, HO-1, PECAM-1, pErk-1, NF-\u03baB, Bcl-2, and cleaved caspase-3 protein expression. Naunyn Schmiedebergs Arch Pharmacol 397(11):9033\u20139050","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"8","key":"3024_CR32","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1007\/s10072-025-08107-9","volume":"46","author":"SR Ahmed","year":"2025","unstructured":"Ahmed SR, Khalil MFE, Ismaiel M et al (2025) Cilostazole versus clopidogrel in acute large-vessel moderate and moderate-to-severe ischemic stroke: a randomized controlled trial. Neurol Sci Aug 46(8):3973\u20133986. https:\/\/doi.org\/10.1007\/s10072-025-08107-9","journal-title":"Neurol Sci Aug"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03024-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03024-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03024-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:06:46Z","timestamp":1785517606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-026-03024-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3024"],"URL":"https:\/\/doi.org\/10.1007\/s13760-026-03024-w","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The current study was approved by the Ethics Committee of the Nanjing Qixia District Hospital (approval number NDH202504122). Written informed consents from all patients were obtained in any experimental work with humans.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}